Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease-Reference-Cited by-同舟云学术

Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease

Published:2023-09 Issue: Volume: Page:
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Martin-Cardona A.^ORCID,Horta D.,Florez-Diez P.,Vela M.,Mesonero F.,Ramos Belinchón C.,García M.J.,Masnou H.,de la Peña-Negro L.,Suarez Ferrer C.,Casanova M.J.,Durán M. Ortiz,Peña E.,Calvet X.,Fernández-Prada S.J.,González-Muñoza C.,Piqueras M.,Rodríguez-Lago I.,Sainz E.,Bas-Cutrina F.,Mancediño Marcos N.,Ojeda A.,Orts B.,Sicilia B.,García A. Castaño,Domènech E.,Esteve M.^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference39 articles.

1. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: diagnosis and medical management;Gomollón;J Crohn's Colitis,2017

2. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 2: surgical management and special situations;Gionchetti;J Crohn's Colitis,2017

3. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders;Magro;J Crohn's Colitis,2017

4. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: Current management;Harbord;J Crohn's Colitis,2017

5. ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease;Kucharzik;J Crohn's Colitis,2021